The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A phase I study of ad.p53 DC vaccine in combination with indoximod in metastatic solid tumors.
Hatem Hussein Soliman
No relevant relationships to disclose
Susan E. Minton
No relevant relationships to disclose
Hyo S. Han
No relevant relationships to disclose
Roohi Ismail-Khan
No relevant relationships to disclose
Amit Mahipal
No relevant relationships to disclose
William Janssen
No relevant relationships to disclose
Howard Streicher
No relevant relationships to disclose
Nicholas N. Vahanian
Employment or Leadership Position - Newlink Genetics
Stock Ownership - Newlink Genetics
Charles J. Link
Employment or Leadership Position - Newlink Genetics
Stock Ownership - Newlink Genetics
William Jay Ramsey
Employment or Leadership Position - Newlink Genetics
Stock Ownership - Newlink Genetics
Scott J. Antonia
No relevant relationships to disclose
Daniel Sullivan
No relevant relationships to disclose